Clinical trial
Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
NCT03833336
Study timeline
Study start (actual)2017-08-23Date precision: day
Registry last updated2025-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ferropenic Anemiaunresolved
Interventions
PlaceboOTHER
Ferric carboxymaltoseDRUG · verified · RxNorm: ferric carboxymaltose
Sucrosomial IronDRUG
Sponsors & collaborators
Institut de Recerca Biomèdica de Lleidalead sponsor
Fundació La Marató de TV3collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03833336 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.